This article is a correction to:
Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
Michael B. VanElzakker
Sydney A. Brumfield
Paula S. Lara Mejia- Division of Neurotherapeutics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
A Corrigendum on
Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
by VanElzakker, M. B., Brumfield, S. A., and Lara Mejia, P. S. (2019). Front. Neurol. 9:1033. doi: 10.3389/fneur.2018.01033
In the original article, there were some minor mistakes in Table A1. Cytokine studies of ME/CFS as published. We have added clarifying or corrective details to several papers listed in the table, and we have added text to the figure legend to clarify its organization. We have corrected instances in which Blundell et al. (104) reported some studies' cytokine findings as “no significant difference,” when the original paper had actually reported those cytokines as below detection level. We have corrected instances in which cited papers made typographical or counting errors in their reported findings. We have added Stringer et al. (142), which was not included in the original table but should have been.
The corrected Table A1. Cytokine studies of ME/CFS appears below.
TABLE A1
Table A1. Cytokine studies of ME/CFS.
In the original article, the reference for Hardcastle et al. (2015) was incorrectly written as Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, et al. Longitudinal analysis of immune abnormalities in varying severities of chronic fatigue syndrome/myalgic encephalomyelitis patients. J Trans Med. (2015) 13:299. doi: 10.1186/s12967-015-0653-3
That citation should have instead been: Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, et al. Serum immune proteins in moderate and severe chronic fatigue syndrome/myalgic encephalomyelitis patients. Int J Med Sci. (2015) 12:764–72. doi: 10.7150/ijms.12399
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
References
128. Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, et al. Serum immune proteins in moderate and severe chronic fatigue syndrome/myalgic encephalomyelitis patients. Int J Med Sci. (2015) 12:764–72. doi: 10.7150/ijms.12399
134. Royal College Pediatrics & Child Health. Evidence Based Guideline for the Management of CFS/ME in Children and Young People (2004).
135. National Institutes of Health and Clinical Excellence. Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management. Clinical guideline [CG53] (2007). Available online at: https://www.nice.org.uk/guidance/cg53
137. Jason LA, Evans M, Porter N, Brown M, Brown A, Hunnell J, et al. The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am J Biochem Biotechnol. (2010) 6:120–35. doi: 10.3844/AJBBSP.2010.120.135
Keywords: myalgic encephalomyelitis, neuroimaging, glia, microglia, PBR28, cytokines, translocator protein, positron emission tomography
Citation: VanElzakker MB, Brumfield SA and Lara Mejia PS (2020) Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods. Front. Neurol. 11:863. doi: 10.3389/fneur.2020.00863
Received: 13 April 2020; Accepted: 07 July 2020;
Published: 17 September 2020.
Edited and reviewed by: Kenneth Joseph Friedman, New Jersey Medical School, Rutgers, The State University of New Jersey, United States
Copyright © 2020 VanElzakker, Brumfield and Lara Mejia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Michael B. VanElzakker, vanelzak@nmr.mgh.harvard.edu